Nektar (NKTR) Shares Resume Trading Up 10%
Tweet Send to a Friend
Up)
Shares of Nektar (Nasdaq: NKTR) have resumed trading up about 10 percent upon resumption following news the company will sell the royalties for Cimzia and Mircera for $124 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
- Independent Bank (INDB) to Acquire Mayflower (MFLR)
- Marketo (MKTO) IPO Opens 54% Higher
Create E-mail Alert Related Categories
Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
